Opportunity status:
Open
Funders:
Medical Research Council (MRC)
Funding type:
Grant
Total fund:
£11,000,000
Publication date:
26 November 2025
Opening date:
10 December 2025 9:00am UK time
Closing date:
4 March 2026 4:00pm UK time
Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions.
You must be invited to apply for stage two of this funding opportunity.
Your project can start and finish at any stage on the developmental pathway from early development, through pre-clinical refinement and testing to early-phase clinical studies and trials (up to phase 2a).
There is no limit on the amount of funding you can apply for, but it should be appropriate to the project. We usually fund 80% of a project’s full economic cost.
This is an ongoing funding opportunity. Application rounds close every March, July and November.
MRC funds high-quality biomedical and health research across discovery, translational, and strategic priorities. Your project should clearly sit within these areas and advance understanding of human health or disease.
👉 Success predictor: Clearly articulate how your project contributes to MRC’s mission and current priority themes in health research.
MRC peer review focuses heavily on:
Scientific quality and novelty
Clarity of hypotheses and aims
Appropriate methodology
Reviewers look for proposals that are innovative, well-designed, and likely to yield important new insights.
👉 Success predictor: Craft a narrative that shows the importance and originality of the research question and the rigor of your approach.
MRC panels include experts across disciplines; proposals need to be accessible to both specialists and informed generalists.
A clear rationale with concise aims helps reviewers quickly grasp your project.
Avoid overly technical language early in the application.
👉 Success predictor: Write for clarity — compelling storytelling linked to solid science increases reviewer engagement.
Reviewers assess feasibility — whether you can do what you propose — and need:
Well-justified sample sizes, power calculations, design choices
Appropriate analytical methods
Contingency plans for likely risks or challenges
This demonstrates that your project can realistically be delivered within the timeline and budget.
👉 Success predictor: Ensure your methods tie directly to your aims and anticipate challenges.
Although not always essential, preliminary data can significantly strengthen your case by showing:
Feasibility
Potential for success
Prior expertise in the area
👉 Success predictor: Include meaningful initial data, or strong theoretical justification when data aren’t possible.
Your application should demonstrate that:
The research team has the right expertise
The lead researcher will drive the project
The institution backs the work with appropriate resources and support
Letters of support (when required) signal collaborative commitment and team capability.
👉 Success predictor: Highlight relevant expertise, roles, and institutional commitment clearly.
MRC scrutinises budgets against project aims to ensure value for public research investment.
Provide realistic costs
Justify each resource
Don’t under- or over-request funds relative to deliverables
👉 Success predictor: A justified, balanced budget that clearly ties to project tasks.
If your research involves humans, animals, tissues or data, your proposal must:
Address ethical considerations
Outline necessary approvals and welfare standards
This reassures reviewers and administrators that the project is responsibly designed.
👉 Success predictor: Include all ethical and regulatory plans/approvals upfront.
Before submitting, follow MRC’s recommended checks:
✔ Correct templates and formatting
✔ Realistic start date
✔ Required attachments (CV, data management plan, letters)
✔ Eligibility checks
✔ Internal or mock review for feedback
👉 Success predictor: A polished, compliant application avoids administrative rejection and focuses reviewers on merit.
MRC uses peer review followed by panel or board decisions. Your proposal is scored by referees then considered collectively; strong narratives and clarity help in both stages.
👉 Success predictor: Aim for balance — detailed enough for experts, clear enough for general reviewers.
Match MRC remit and priorities
Compelling, innovative scientific idea
Clear aims and narrative
Sound methodology with risk mitigation
Preliminary data or strong rationale
Strong team and institutional commitment
Justified budget
Regulatory and ethical readiness
Final compliance checks before submission
You can only apply for this funding opportunity if we have invited you to do so following a successful stage one application.
This funding opportunity is open to organisations with standard eligibility. Check if your organisation is eligible.
Who is eligible to apply
To be eligible to apply for this funding opportunity you must:
If you do not have a contract of employment for the duration of the proposed project, by submitting an application the research organisation is confirming, if it is successful:
International researchers
As Medical Research Council (MRC) is a lead funder for this funding opportunity, international researchers can apply as ‘project co-lead (international)’.
Project co-leads (international) make a major intellectual contribution to the design or conduct of the project. Their contribution and added value to the research should be clearly explained and justified in the application, see Applicant and team capability to deliver.
Read the UKRI project co-lead (international) eligibility for more details. Contact us if you are uncertain about eligibility.
You should include all other international collaborators as project partners.
Equality, diversity and inclusion
We are committed to achieving equality of opportunity for all funding applicants. We encourage applications from a diverse range of researchers.
We support people to work in a way that suits their personal circumstances. This includes:
UKRI can offer disability and accessibility support for UKRI applicants and grant holders during the application and assessment process.
Sponsor Institute/Organizations: Medical Research Council (MRC)
Sponsor Type: Corporate/Non-Profit
Address: Polaris House Swindon SN2 1FL
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Mar 04, 2026
Mar 04, 2026
$12,979,065
Affiliation: Medical Research Council (MRC)
Address: Polaris House Swindon SN2 1FL
Website URL: https://www.ukri.org/opportunity/developmental-pathway-funding-scheme-stage-two-application/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.